In COVID-19, there is documented evidence of a prothrombotic and proinflammatory state seen among severe and critically ill patients under hospitalization, marked by elevated levels of D-dimer and fibrinogen, prolonged prothrombin times, and the activation of proinflammatory cytokines, among others [33]. This evidence concerns the gene F2 and COVID-19.